About Anti-Müllerian Hormone Test

Definition

Anti-Müllerian hormone (AMH) is a hormone produced in the ovaries or testicles. In unborn babies, the hormone helps development of the male and female reproductive organs. In adults, it is used as a biomarker to measure ovarian reserve, which refers to the number of eggs a person has. The AMH test is done to provide information about a person's ovarian function and fertility potential.

The AMH test is commonly used in assisted reproduction, such as in vitro fertilization (IVF), to assess a person's response to ovarian stimulation. It can also be used to diagnose and predict conditions such as polycystic ovary syndrome (PCOS), early menopause, and premature ovarian insufficiency (POI). Additionally, AMH measurement can be helpful in identifying tumors originating from granulosa cells in females and Sertoli cells in males.

The test is performed by collecting a blood sample from the individual. This sample is then sent to a laboratory for analysis. The results of the AMH test can provide valuable information about a person's reproductive health and help guide fertility treatments or interventions if needed.

In summary, the Anti-Müllerian hormone test measures the level of AMH in the blood and is used to assess ovarian reserve and reproductive potential. It can help diagnose conditions like PCOS and guide fertility treatments.

Prior to Lab Test

Before undergoing the Anti-Müllerian hormone test, there are several instructions that should be followed:

  • Avoid exercise or strenuous physical activity the day before the test.
  • Drink plenty of fluids over the 24-hour period preceding the test.
  • Get an adequate amount of sleep (6-8 hours) the night before the test.
  • Avoid substances such as tobacco, alcohol, or stimulants (caffeine, theine, taurine, etc.) in the 8 hours leading up to the test.
  • Avoid food intake for 3 hours prior to performing the test.
  • Wear comfortable, loose-fitting clothing.

These instructions help ensure accurate results and minimize any potential interference with the hormone levels being measured during the Anti-Müllerian hormone test.

How the Lab Test is Done

To perform the Anti-Müllerian hormone test, samples are collected and processed in a step-by-step manner. Here is a description of the process:

  • Venous blood collection: A healthcare professional will collect a sample of venous blood from your arm. This is usually done using a needle and a syringe or a vacuum tube. The blood is collected 13 days before surgery (AMH 1) and about 6 months after surgery (AMH 2).
  • Centrifugation: The collected blood sample is then placed in a centrifuge machine, which spins the sample at high speed. This process separates the different components of the blood, such as red blood cells, white blood cells, and plasma.
  • Measurement of AMH level: After centrifugation, the serum (the clear liquid portion of the blood) is used to measure the concentration of Anti-Müllerian hormone (AMH). AMH is a substance produced by the ovaries.
  • Electrochemiluminescence method: The concentration of AMH is determined using a technique called electrochemiluminescence immunoassay (ECLIA). In this method, a sandwich immunochemical test is performed.
  • Antibody incubation: In the first stage of the test, the serum sample is mixed with biotinylated antibodies that are specific for AMH. These antibodies bind to the AMH antigen present in the sample.
  • Ruthenium-labeled antibodies: Monoclonal antibodies labeled with a ruthenium complex are then added to the mixture. These antibodies also bind to the AMH antigen.
  • Streptavidin-coated microparticles: Streptavidin-coated microparticles are introduced into the mixture. These microparticles have an affinity for biotin.
  • Binding reaction: The biotin on the antibodies and streptavidin-coated microparticles form a complex that binds to solid phase surfaces in the test system.
  • Removal of unbound substances: Any unbound substances are washed away using a buffer solution.
  • Electrochemiluminescence reaction: An electrical voltage is applied to an electrode in the test system, which induces an electrochemiluminescence reaction. This reaction leads to the emission of photons at a wavelength of 620 nm.
  • Photon measurement: The emitted photons are measured using a photomultiplier tube, which detects and quantifies their intensity.
  • Result interpretation: The reading of photon emission is inversely proportional to the concentration of AMH in the sample. Based on this measurement, healthcare professionals can determine your AMH level and interpret the results accordingly.

This step-by-step process allows healthcare professionals to accurately measure your Anti-Müllerian hormone levels and assess your ovarian reserve, which can provide valuable information about fertility potential and reproductive health.

Understanding Results

The normal range for Anti-Müllerian hormone (AMH) test results can vary depending on the laboratory, but generally, a normal result is considered to be between 2-15iu/L. Results higher than 15iu/L are considered high, while results lower than 2iu/L are considered low.

The diagnostic implication of the AMH test results depends on the specific condition being evaluated. For example, in the diagnosis of menstrual disturbance due to polycystic ovarian syndrome (PCOS), higher levels of AMH have been found in women with menstrual disturbance compared to those with regular cycles. In fact, the odds of menstrual disturbance were increased by 28.5-fold in women with serum AMH levels above 60 pmol/L compared to those with levels below 15 pmol/L.

In females of childbearing age, higher levels of AMH mean that the ovaries have a larger supply of eggs. As females age, the number of eggs decreases, which causes AMH levels and fertility to decrease. In females undergoing treatment for infertility, AMH may be used to help guide the dose of fertility medication.

It's important to note that the diagnostic implications of AMH test results may vary depending on the specific condition being evaluated and individual patient factors. Therefore, it is always recommended to consult with a healthcare provider who can interpret the results in the context of your specific situation and provide appropriate guidance and treatment options.